QC
TNDM icon

Quadrature Capital’s Tandem Diabetes Care TNDM Stock Holding History

Quadrature Capital’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-26,756
Closed -$325K – 1651
2025
Q3 		$325K Buy
+26,756
New +$362K ﹤0.01% 646

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Quadrature Capital's TNDM Position: Q4 2025 in Review

Quadrature Capital sold out of Tandem Diabetes Care (TNDM) in Q4 2025, closing a stake of 26,756 shares — an estimated $325K sold.

Quadrature Capital first reported a position in TNDM in Q3 2025 and held it in 1 quarter. The position peaked at $325K in Q3 2025. 268 funds tracked by Wall St. Rank hold TNDM as of Q4 2025.

  • Quadrature Capital reported no remaining Tandem Diabetes Care position as of Q4 2025 after selling out during the quarter.
  • Quadrature Capital sold 26,756 Tandem Diabetes Care shares in Q4 2025, an estimated $325K.
  • Quadrature Capital first reported a position in Tandem Diabetes Care in Q3 2025 and held it in 1 quarter.
  • Quadrature Capital's Tandem Diabetes Care position peaked at $325K in Q3 2025.
  • 268 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2025.

Based on Quadrature Capital's 13F filing for Q4 2025, filed 17 Feb 2026.